story of the week
Efficacy of Pembrolizumab in Non-Colorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
J. Clin. Oncol 2019 Nov 04;[EPub Ahead of Print], A Marabelle, DT Le, PA Ascierto, AM Di Giacomo, A De Jesus-Acosta, JP Delord, R Geva, M Gottfried, N Penel, AR Hansen, SA Piha-Paul, T Doi, B Gao, HC Chung, J Lopez-Martin, YJ Bang, RS Frommer, M Shah, R Ghori, AK Joe, SK Pruitt, LA DiazFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.